Cargando…
Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
Large scale exome sequencing studies have revealed regions of the genome, which contribute to the castrate resistant prostate cancer (CRPC) phenotype.123 Such studies have identified mutations in genes, which may have diagnostic/prognostic potential, or which may be targeted therapeutically. Two of...
Autores principales: | Lai, John, Batra, Jyotsna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215653/ https://www.ncbi.nlm.nih.gov/pubmed/24969063 http://dx.doi.org/10.4103/1008-682X.133323 |
Ejemplares similares
-
Speckle-type POZ protein mutations in prostate cancer: a new part of the mosaic
por: Stoehr, Robert
Publicado: (2015) -
Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability
por: Wei, Xi, et al.
Publicado: (2018) -
Identification of speckle-type POZ protein somatic mutations in African American prostate cancer
por: Buckles, Eric, et al.
Publicado: (2014) -
The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1
por: Wei, Chunli, et al.
Publicado: (2022) -
Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation
por: Yao, Sumei, et al.
Publicado: (2018)